Steve Chappell Mitchell
22Patents
6h-index
11Co-inventors
62Inventor score
Filing activity: Oct 5, 2000 → Jun 28, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7507541B2 | 36P6D5: secreted tumor antigen | Emerging Cross-Sectional Technologies | 77 | Active |
| US7459539B2 | Antibody that binds zinc transporter protein 108P5H8 | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7510840B1 | Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6893818B1 | Gene upregulated in cancers of the prostate | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7223542B2 | 36P6D5: secreted tumor antigen | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6566078B1 | 36P6D5: secreted tumor antigen | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6835822B1 | Diagnosis and therapy of cancer using SGP28-related molecules | Chemistry; Metallurgy | 3 | Expired |
| US6924358B2 | 121P1F1: a tissue specific protein highly expressed in various cancers | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7771968B2 | Gene upregulated in cancers of the prostate | Emerging Cross-Sectional Technologies | 1 | Active |
| US7271240B2 | 125P5C8: a tissue specific protein highly expressed in various cancers | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7897740B2 | Secreted protein called 36P6D5 characteristic of tumors | Emerging Cross-Sectional Technologies | 0 | Active |
| US6790631B1 | G protein-coupled receptor up-regulated in prostate cancer and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US7199220B2 | 103P2D6: tissue specific protein highly expressed in various cancers | Chemistry; Metallurgy | 0 | Expired |
| US7510855B2 | 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7534417B2 | 103P2D6: tissue specific protein highly expressed in various cancers | Chemistry; Metallurgy | 0 | Expired |
| US7172898B2 | 103P2D6: tissue specific protein highly expressed in various cancers | Chemistry; Metallurgy | 0 | Expired |
| US8013126B2 | 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US7968283B2 | Gene expressed in prostate cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US7834156B2 | 125P5C8: tissue specific protein highly expressed in various cancers | Emerging Cross-Sectional Technologies | 0 | Active |
| US6838258B2 | G protein-coupled receptor up-regulated in prostate cancer and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US7928212B2 | Gene upregulated in cancers of the prostate | Emerging Cross-Sectional Technologies | 0 | Active |
| US8101372B2 | Diagnosis and therapy of cancer using SGP28-related molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.